More tools:Markets·Screener·Research·Chat

Biote Corp. Class A Common Stock (BTMD) Financial Statements

Biote Corp. Class A Common Stock
SIC 2833 · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
FIGI BBG00ZCMCC37
XNAS · usd
1.51▼ 0.03 (-2.27%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close1.55
Day's Range1.45 – 1.56
52-Week Range1.27 – 3.58
Volume119.5K
Avg Volume308.9K
Share Statistics
Shares Outstanding
Employees223
ExchangeXNAS
Listed2022-05-27
Share count as of August 5, 2026
Loading Income Statement…
Key questions about Biote Corp. Class A Common Stock (BTMD)
What is Biote Corp. Class A Common Stock's Market Cap?
Biote Corp. Class A Common Stock's Market Cap is $54.3M, based on as-reported figures from SEC (XBRL) filings.
What is Biote Corp. Class A Common Stock's Enterprise Value?
Biote Corp. Class A Common Stock's Enterprise Value is $164.6M, based on as-reported figures from SEC (XBRL) filings.
What is Biote Corp. Class A Common Stock's Trailing P/E?
Biote Corp. Class A Common Stock's Trailing P/E is 9.3×, based on as-reported figures from SEC (XBRL) filings.
What is Biote Corp. Class A Common Stock's Price / Sales?
Biote Corp. Class A Common Stock's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is Biote Corp. Class A Common Stock's EV / Revenue?
Biote Corp. Class A Common Stock's EV / Revenue is 0.9×, based on as-reported figures from SEC (XBRL) filings.
What is Biote Corp. Class A Common Stock's EV / EBITDA?
Biote Corp. Class A Common Stock's EV / EBITDA is 9.4×, based on as-reported figures from SEC (XBRL) filings.
What is Biote Corp. Class A Common Stock's Revenue (TTM)?
Biote Corp. Class A Common Stock's Revenue (TTM) is $183.5M, based on as-reported figures from SEC (XBRL) filings.
What is Biote Corp. Class A Common Stock's Net Income (TTM)?
Biote Corp. Class A Common Stock's Net Income (TTM) is $5.9M, based on as-reported figures from SEC (XBRL) filings.
What is Biote Corp. Class A Common Stock's EBITDA?
Biote Corp. Class A Common Stock's EBITDA is $18.6M, based on as-reported figures from SEC (XBRL) filings.
What is Biote Corp. Class A Common Stock's Diluted EPS (TTM)?
Biote Corp. Class A Common Stock's Diluted EPS (TTM) is 0.16, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
Total revenue
YoY growth-9.7%-6.9%-6.7%
Cost of revenue
Cost of revenue
Selling, general, and administrative
Income (loss) from operations
% of revenue-7.9%14.7%17.2%
Other income (expense) net :
Interest expense, net
Loss on extinguishment of debt——
Gain (loss) from change in fair value of earnout liabilities
Other income (expense), net
Total other income (expense), net
Income (loss) before provision for income taxes
Income tax expense
Net income (loss)
% of revenue-16.8%5.6%19.2%
Less: Net income (loss) attributable to noncontrolling interest
Net income (loss) attributable to biote Corp. stockholders
% of revenue-14.8%4.2%17.1%
Basic
Diluted